Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining -1.77% today. In the last week its performance is 0.73%, and -20.68% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 67.5, so today’s gain of -1.77% is a significant step towards its target price. The GAP today is therefore -0.39%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 92699.31, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.30%.

At the current price of 55.48, it has a dividend yield of 2.74%, and its target price is 67.5. This is with a profit margin of 16.30%, and total debt/equity of 0.45. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 32.46, as well as a forward P/E of 18.51.

With a current EPS of 1.71, and a forecasted EPS growth for next year at 14.26%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 19.59%.

Performance for the year is -5.76%. Since its IPO date on 6/1/1972, the total performance to date is -18.44%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 8587400, while its average volume is 11192.61. Whilst the total gain today was -1.77%, it did have a day high of -28.06%.

Volatility for this week has been at 1.57%, and 1.87% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 0.84%, while the 52-week-high has reached -28.06%.

Looking at its return of investments, which is 4.60%, and its return on assets is 9.00%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 20.80%. With a sales growth of 17.00% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.44, and has a current ratio of 1.6 and 1.4 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 1.66, and the P/S is 5.26, along with a P/B of 6.21. Meanwhile it has a p/cash of 19.93.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment